Publication | Closed Access

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

MedicineColorectal CancerPathologyImmune Checkpoint InhibitorIpilimumab Versus NivolumabCheckmate 8HwCancer GeneticsOncologyRadiation Oncology